Abstract: A pharmaceutical composition for ischemia treatment of a patient includes a ginkgo extraction and a pharmaceutically acceptable carrier. The dosage form of the pharmaceutical composition is gel, transdermal patch, cream or paste. The patient is a neonate, an infant, or an early child. A use of the pharmaceutical composition for ischemia treatment of a patient is disclosed.
Abstract: A use of a nucleic acid molecule mediating RNA interference for treating or reducing pain is disclosed. The nucleic acid molecule has a sequence selected from the group consisting of SEQ ID NO:1, SEQ ID NO:2, SEQ ID NO:3 and SEQ ID NO:4, and is used for effectively inhibiting expression of bradykinin B2 receptor, treating or reducing pain and preparing a pharmaceutical composition for reducing neuropathic pain.
Type:
Grant
Filed:
July 14, 2011
Date of Patent:
May 21, 2013
Assignees:
Fu-Jen Catholic University, Shin Kong Wu Ho Su Memorial Hospital
Abstract: A use of a nucleic acid molecule mediating RNA interference for treating or reducing pain is disclosed. The nucleic acid molecule has a sequence selected from the group consisting of SEQ ID NO:1, SEQ ID NO:2, SEQ ID NO:3 and SEQ ID NO:4, and is used for effectively inhibiting expression of bradykinin B2 receptor, treating or reducing pain and preparing a pharmaceutical composition for reducing neuropathic pain.
Type:
Application
Filed:
July 14, 2011
Publication date:
November 15, 2012
Applicants:
SHIN KONG WU HO SU MEMORIAL HOSPITAL, FU-JEN CATHOLIC UNIVERSITY
Abstract: The present invention relates to methods of diagnosing myasthenia gravis in a subject, by determining an amount of at least one autoantibody that specifically binds one or more autoantigens selected from heat-shock protein 60 (hsp60), heat-shock protein 90, alpha isoform (hsp90?), and heat-shock protein 90, beta isoform (hsp90?). The invention also provides diagnostic kits for identifying a subject having myasthenia gravis.
Type:
Grant
Filed:
December 29, 2005
Date of Patent:
October 5, 2010
Assignees:
Industrial Technology Research Institute (ITRI), National Health Research Institutes (NHRI), Shin Kong Wu Ho-Su Memorial Hospital